{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:49:24Z","timestamp":1782506964850,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.celrep.2026.117322","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:38:09Z","timestamp":1778762289000},"page":"117322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initial vaccination platform against S. pneumoniae shapes antibody profiles upon revaccination with pneumococcal conjugate vaccine in older adults"],"prefix":"10.1016","volume":"45","author":[{"given":"Qixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela R.L.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Malca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shih-Lu Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Vojicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-3532","authenticated-orcid":false,"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117322_bib1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117322_bib2","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.celrep.2026.117322_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.vaccine.2019.12.023","article-title":"Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals","volume":"38","author":"Sterrett","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41590-023-01717-5","article-title":"Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults","volume":"25","author":"Ravichandran","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117322_bib5","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cid\/ciy312","article-title":"Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117322_bib7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117322_bib8","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib9","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2015.07.059","article-title":"Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes","volume":"33","author":"Boelsen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12050732","article-title":"Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults","volume":"12","author":"Farrar","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.celrep.2026.117322_bib11","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117322_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117322_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117322_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03036-23","article-title":"Understanding Fc function for rational vaccine design against pathogens","volume":"15","author":"Bowman","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117322_bib15","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-na\u00efve adults 60-64 years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib16","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.294.21.2712","article-title":"Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002","volume":"294","author":"Fry","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2026.117322_bib17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117322_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm4065","article-title":"Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses","volume":"14","author":"Davies","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117322_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113292","article-title":"Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines","volume":"42","author":"Deng","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117322_bib20","article-title":"Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern","volume":"14","author":"McNamara","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117322_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: a new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117322_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.smim.2009.02.003","article-title":"Biochemical signaling pathways for memory T cell recall","volume":"21","author":"Farber","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2026.117322_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-023-00791-y","article-title":"Boosting with adjuvanted SCB-2019 elicits superior Fc\u03b3-receptor engagement driven by IgG3 to SARS-CoV-2 spike","volume":"9","author":"Jung","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.celrep.2026.117322_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1172\/JCI129520","article-title":"Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination","volume":"130","author":"Boudreau","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117322_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","article-title":"Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA","volume":"9","author":"Li","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2026.117322_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41564-024-01678-x","article-title":"Age and sex influence antibody profiles associated with tuberculosis progression","volume":"9","author":"Davies","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2026.117322_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110724","article-title":"Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine","volume":"18","author":"Wu","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.celrep.2026.117322_bib28","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2026.117322_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005101","article-title":"Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge","volume":"11","author":"Tuero","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117322_bib30","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117322_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110174","article-title":"Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques","volume":"27","author":"Tong","year":"2024","journal-title":"iScience"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726004006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726004006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:32:04Z","timestamp":1782505924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726004006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211124726004006"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117322","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial vaccination platform against S. pneumoniae shapes antibody profiles upon revaccination with pneumococcal conjugate vaccine in older adults","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117307","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117322"}}